EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Neurovascular dysfunction in diabetic retinopathy: mechanisms and therapeutic perspectives

Xi Hu, Chenhao Gu, Ying Liu, Yuqi Cao, Jiadi Wang, Jing Yao

Frontiers in Endocrinology · 2026-11-12 · 17

DOI: 10.3389/fendo.2026.2003705 ↗
AbstractBibliografische Angaben

Abstract

Diabetic retinopathy (DR) involves dysfunction of the retinal neurovascular unit (NVU) in addition to clinically detectable microvascular lesions. This narrative review critically examines how metabolic and organelle stress, neuroglial inflammation, and blood–retinal barrier dysfunction contribute to impaired retinal homeostasis. We propose an evidence-to-decision framework that distinguishes candidate initiating mechanisms, disease amplifiers, persistence programs, and potential treatment-escape pathways according to the strength of causal evidence and clinical relevance. Findings from human studies, experimental models, and clinical trials are evaluated separately to avoid conflating molecular associations with established mechanisms of disease progression. Particular attention is given to the distinction between clinical metabolic memory and experimentally demonstrated molecular persistence, as well as between alternative angiogenic signaling and clinically validated resistance to vascular endothelial growth factor inhibition. Emerging imaging, electrophysiological, and molecular biomarkers may help characterize neurovascular heterogeneity, but their prognostic and predictive value remains insufficiently established. We identify key experimental and clinical studies needed to validate mechanistic hypotheses, clarify their relationship to functional outcomes, and assess their therapeutic relevance. This synthesis provides a framework for prioritizing testable mechanisms while emphasizing that mechanism-guided patient stratification and treatment selection require prospective clinical validation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →